cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting $pirs via 
Managed Corporate Credit currently a Trader / Investor. Mostly using my Feed to Journal my DayTrading Notes. Watch List Summary Posted Most Weekdays by 9am EST.